brimonidine tartrate has been researched along with endothelin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dina, JP; Feres, T; Paiva, AC; Paiva, TB | 1 |
| Aktaş, Z; Akyürek, N; Gürelik, G; Hasanreisoğlu, B; Onol, M | 1 |
2 other study(ies) available for brimonidine tartrate and endothelin-1
| Article | Year |
|---|---|
Role of membrane potential and expression of endothelial factors in restenosis after angioplasty in SHR.
Topics: Adrenergic alpha-Agonists; Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Brimonidine Tartrate; Carotid Arteries; Endothelin-1; Endothelium, Vascular; Hypertension; In Vitro Techniques; Male; Membrane Potentials; Nitric Oxide; Peptides; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Wistar | 2004 |
Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Apoptosis; Brimonidine Tartrate; Cell Count; Disease Models, Animal; Endothelin-1; Infusion Pumps, Implantable; Neuroprotective Agents; Optic Neuropathy, Ischemic; Quinoxalines; Rabbits; Retina; Retinal Ganglion Cells | 2007 |